Autonomic Reflexes During Intra-arterial Chemotherapy for Retinoblastoma
Cardiorespiratory Autonomic Reflexes During Superselective Ophthalmic Artery Chemotherapy for Retinoblastoma in Children: a Prospective Observational Study.
1 other identifier
observational
200
1 country
1
Brief Summary
Prospective observational study in patients undergoing intra-arterial ophthalmic artery chemotherapy for the treatment of retinoblastoma. The main objective of the study is to evaluate the incidence of cardiorespiratory autonomic reflexes in these patients and to investigate the association between autonomic reflexes and perioperative clinical characteristics.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 15, 2020
CompletedFirst Submitted
Initial submission to the registry
June 25, 2020
CompletedFirst Posted
Study publicly available on registry
June 30, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 15, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
July 15, 2021
CompletedJune 30, 2020
June 1, 2020
1.1 years
June 25, 2020
June 25, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Cardiorespiratory autonomic reflexes incidence
To evaluate the incidence of cardiorespiratory autonomic reflexes during intra-arterial chemotherapy of the ophthalmic artery in a child cancer center.
from the admission of the patient in the operating room until the end of the procedure (intra-arterial chemotherapy)
Secondary Outcomes (1)
Clinical background and autonomic reflexes occurence
from the admission of the patient in the operating room until the end of the procedure.
Eligibility Criteria
Children undergoing cancer treatment for unilateral or bilateral retinoblastoma at the Instituto de Oncologia Pediátrica da Universidade Federal de São Paulo - GRAACC, São Paulo - Brasil.
You may qualify if:
- All patients diagnosed with retinoblastoma and submitted to intra-arterial chemotherapy during the study period
- Informed consent form signed and dated by legal guardian and investigator
- Informed assent form signed by the patient if appropriate
You may not qualify if:
- Refusal of the patient or guardian to participate in the research project
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Federal University of Sao Paulo
São Paulo, São Paulo, 04023-062, Brazil
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mariana F Lima, MD, PhD
Federal University of São Paulo
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 25, 2020
First Posted
June 30, 2020
Study Start
June 15, 2020
Primary Completion
July 15, 2021
Study Completion
July 15, 2021
Last Updated
June 30, 2020
Record last verified: 2020-06